SR-4835 - 10mM in DMSO , CAS No.2387704-62-1

CAS: 2387704-62-1 Cat. No.: S422796 Summenformel: C21H20Cl2N10O Molekulargewicht: 499.36
Zu bestellen verfügbar
GRADE & PURITY 10mM in DMSO
Synonyms
9H-​Purin-​6-​amine,N-​[(5,​6-​dichloro-​1H-​benzimidazol-​2-​yl)​methyl]​-​9-​(1-​methyl-​1H-​pyrazol-​4-​yl)​-​2-​(4-​morpholinyl)​-
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Size
Deutschland (EU)
USA*
Price
Qty
1ml
S422796-1ml
—
2 Auf Lager
78,01€
Enter a quantity for the sizes you want to add.
🧪

Why this grade

10mM in DMSO for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -80°C Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Übersicht

Information

SR-4835 SR-4835 is a highly selective dual inhibitor of CDK12 and CDK13 with IC50 of 99 nM and Kd of 98 nM for CDK12 and IC50 of 4.9 nM for CDK13. SR-4835 disables triple-negative breast cancer (TNBC) cells. SR-4835 promotes synergy with DNA-damaging chemotherapy and PARP inhibitors.

Targets

CDK13 (Cell-free assay); CDK12 (Cell-free assay); CDK12 (Cell-free assay) 4.9 nM; 98 nM(Kd); 99 nM

In vitro

SR-4835 is a selective, potent dual inhibitor of CDK12 and CDK13, suppressing expression of DDR proteins. CDK12/CDK13 inhibition synergizes with DNA-damaging agents or PARP inhibition to trigger TNBC cell death.

In vivo

SR-4835 has potent in vivo anti-TNBC activity and augments the anti-cancer activity of cisplatin, irinotecan, and olaparib, which are standard-of-care therapeutics for TNBC. SR-4835 is well tolerated in mice after long-term dosing. SR-4835 cooperates with DNA-damaging chemotherapeutics.

Cell Research(from reference)

Cell lines:Human: MDA-MB-231, MDA-MB-436, HS578T, MDA-MB-468, FHC 

Concentrations:10-90 nM, 0.4-10 μM 

Incubation Time:4 h, 6 h, 72 h 

Specifications

Synonyme
9H-​Purin-​6-​amine,N-​[(5,​6-​dichloro-​1H-​benzimidazol-​2-​yl)​methyl]​-​9-​(1-​methyl-​1H-​pyrazol-​4-​yl)​-​2-​(4-​morpholinyl)​-
Spezifikationen & Reinheit
10mM in DMSO
Biochemische und physiologische Mechanismen
SR-4835 is a highly selective dual inhibitor of CDK12 and CDK13 with IC50 of 99 nM and Kd of 98 nM for CDK12 and IC50 of 4.9 nM for CDK13. SR-4835 disables triple-negative breast cancer (TNBC) cells. SR-4835 promotes synergy with DNA-damaging chemotherapy
Storage
Store at -80°C
Verschickt in
Dry ice packs + Cold packs
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Produkteigenschaften
ALogP3.538
hba_count6
HBD-Zahl2
Rotationsfähige Bindung5
Namen und Kennungen
Isomere SMILES CN1C=C(C=N1)N2C=NC3=C(N=C(N=C32)N4CCOCC4)NCC5=NC6=CC(=C(C=C6N5)Cl)Cl
Molekulargewicht 499.36

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Chemische und physikalische Eigenschaften
DMSO (mg/ml) Maximale Löslichkeit100
DMSO (mM) Maximale Löslichkeit200.256328099968
Wasser (mg/ml) Maximale Löslichkeit<1
Lösungsrechner
Bewertungen

Kundenbewertungen

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.